Zacks Investment Research
21 Oct 2026, 20:46 UTC · 54m ago
Elevance Health, Inc. (ELV) Hits Fresh High: Is There Still Room to Run?
Impact · against what's priced in
Elevance Health's significant earnings beat suggests a possible recovery in profitability that the market has not yet factored into its valuation. While the stock has reached new highs, the current price explicitly discounts a recovery in margins and free cash flow, making this beat a potential catalyst for further upside.
- ELV+0.40
Challenges what's priced in
- The price assumes
A recovery in the Health Benefits benefit expense ratio from 89.7% back below 88.5%
The company reported an EPS of $6.99, beating the $4.66 consensus by $2.33; this substantial outperformance suggests that the profitability compression and margin trough the market currently assumes may be reversing.
What ELV's price assumes · Aug 27
